Nutranomics(OTC) NNRX

Market Cap$15.30K

Since IPO (2013)-100%

5 Year-100%

1 Year-98%

1 Month+0%

$0.00

+0.00%

+0.00Today

Nutranomics last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-13

Nutranomics stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-08-05
1 month	+0%	USD 0.00	2026-06-26
3 month	+0%	USD 0.00	2026-05-14
Year to date	+0%	USD 0.00	2025-12-29
1 year	-98%	USD 0.00	2025-08-13
3 year	-98%	USD 0.00	2023-08-14
5 year	-99.87%	USD 0.00	2021-08-13
Since inception	-100%	USD 0.75	2013-09-20

Nutranomics Financials at a Glance

Market Cap

$15.30K

Revenue (TTM)

$3.08M

Net Income (TTM)

-$8.07M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

11.13 (High)

Dividend

$0.00

Beta (Volatility)

11.13 (High)

Price

$0.00

Volume

250,000

Open

$0.00

Price

$0.00

Volume

250,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

11.13 (High)

Price

$0.00

Volume

250,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

NNRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nutranomics

Nutranomics, Inc. is a company dedicated to the research, development, and marketing of health-focused nutritional products. With an extensive catalog of nearly 500 dietary supplements, Nutranomics aims to enhance health and wellness through innovative solutions.

Products and Services

Nearly 500 distinct dietary supplements including vitamins and probiotics
Nutritional Blood Analysis for live blood cell observation
Educational resources and professional certifications for industry experts

Growth Outlook

Revenue increased to 1,008,761 in the latest quarter
Strategic alliances enhance market reach and product offerings
Global distribution network spans North America and Asia

Financial Highlights

Trailing twelve months revenue of 2,175,000
Net income for the latest quarter was -1,522,518
Cash and cash equivalents increased to 299,736 in the latest quarter

Nutranomics, Inc. operates in the Drug Manufacturers - Specialty & Generic industry and is based in Salt Lake City, Utah. The company has developed a unique approach to nutritional health, combining product offerings with educational services to empower consumers and professionals alike. Despite recent financial challenges, including a net loss in the latest quarter, the company has shown resilience with a notable increase in revenue. The strategic alliances and global distribution channels position Nutranomics for potential growth in the health and wellness market. Investors may find interest in the company's innovative products and commitment to enhancing nutrient absorption and overall health.

AI Generated • Jul 30, 2026

Industry

Personal Products

Sector

Consumer Staples

CEO

Jonathan Bishop

Website

www.nutranomics.com

Headquarters

Salt Lake City, UT 84020, US

NNRX Financials

Key Financial Metrics (TTM)

Gross Margin

-108.05%

Operating Margin

-297.40%

Net Income Margin

-232.89%

Return on Equity

99.34%

Return on Capital

-198.21%

Return on Assets

-36.76%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$15.30K

Shares Outstanding

15.32B

Volume

250.00K

Avg. Volume

157.48K

Financials (TTM)

Gross Profit

-$2.70M

Operating Income

-$8.60M

EBITDA

-$2.55M

Operating Cash Flow

-$3.77M

Capital Expenditure

-$184.50K

Free Cash Flow

-$3.95M

Cash & ST Invst.

$299.74K

Total Debt

$23.97M

Nutranomics Performance Analysis

Nutranomics annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-07-31	USD 2,846,786	N/A

Nutranomics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-07-31	17.0%
Q1	2022-10-31	-53.4%
Q2	2023-01-31	49.2%
Q3	2023-04-30	51.1%

Nutranomics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-07-31	USD -0.00	N/A

Nutranomics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-07-31	90.3%
Q1	2022-10-31	66.7%
Q2	2023-01-31	N/A
Q3	2023-04-30	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

$1.01M

+23.0%

Gross Profit

-$249.16K

+82.0%

Gross Margin

-24.70%

N/A

Market Cap

$15.30K

N/A

Market Cap/Employee

$15.30K

N/A

Employees

N/A

Net Income

-$1.52M

-80.6%

EBITDA

-$987.03K

-40.5%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Total Cash

$299.74K

-9.1%

Total Debt

$23.97M

+24.1%

Accounts Receivable

$840.32K

+32.0%

Inventory

$1.25M

+0.8%

Long Term Debt

$13.74M

+3.1%

Short Term Debt

$10.23M

+70.9%

Return on Assets

-36.76%

N/A

Return on Invested Capital

-3.16%

N/A

Free Cash Flow

$156.24K

+104.1%

Operating Cash Flow

$146.88K

+103.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VFRMVeritas Farms, Inc.

VFRMVeritas Farms, Inc.$0.00+0.00%

ACURAcura Pharmaceuticals, Inc.

ACURAcura Pharmaceuticals, Inc.$0.00+0.00%

MRRCFWayland Group Corp.

MRRCFWayland Group Corp.$0.00+0.00%

ENDVEndonovo Therapeutics, Inc.

ENDVEndonovo Therapeutics, Inc.$0.00+0.00%

AXRXAmexdrug Corporation

AXRXAmexdrug Corporation$0.00+0.00%

WIBFFWest Island Brands Inc.

WIBFFWest Island Brands Inc.$0.00+0.00%

TNPHTian'an Pharmaceutical Co., Ltd.

TNPHTian'an Pharmaceutical Co., Ltd.$0.01+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NUNu Holdings

NUNu Holdings$15.23+0.09%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.76+0.01%

ONDSOndas

ONDSOndas$9.24+0.04%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$140.00-0.01%

INTCIntel

INTCIntel$102.50-0.02%

NVDANvidia

NVDANvidia$225.16-0.00%

NOKNokia

NOKNokia$10.76+0.02%

Questions About NNRX

What is the current price of Nutranomics?

Nutranomics is trading at $0.00 per share.

What is the 52-week range for Nutranomics?

Over the past 52 weeks, Nutranomics has traded between $0.00 and $0.00.

How much debt does Nutranomics have?

As of the most recent reporting period, Nutranomics reported total debt of $19.75M.

How much cash does Nutranomics have on hand?

Nutranomics reported $344.80K in cash and cash equivalents in its most recent financial results.

What is Nutranomics’s dividend yield?

Nutranomics does not currently have a dividend yield.

Nutranomics(OTC) NNRX

Nutranomics Financials at a Glance

NNRX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Nutranomics

NNRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Nutranomics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NNRX

What is the current price of Nutranomics?

What is the 52-week range for Nutranomics?

How much debt does Nutranomics have?

How much cash does Nutranomics have on hand?

What is Nutranomics’s dividend yield?

Premium Investing Services